Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000402374 | SCV000339729 | benign | not specified | 2016-03-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001701987 | SCV000528831 | benign | not provided | 2018-06-11 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000528307 | SCV000650968 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002436114 | SCV002748861 | benign | Cardiovascular phenotype | 2019-03-05 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000402374 | SCV004038063 | benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001701987 | SCV004161033 | benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | FLNC: BS1, BS2 |
Clinical Genetics, |
RCV000402374 | SCV001922105 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001701987 | SCV001930759 | likely benign | not provided | no assertion criteria provided | clinical testing |